APA (7th ed.) Citation

Á, R., AJ, D., F, C., R, B., GM, C., L, C., . . . JA, F. (2025). CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy. Nature biomedical engineering. https://doi.org/10.1038/s41551-025-01527-0

Chicago Style (17th ed.) Citation

Á, Ramírez-Fernández, et al. "CCR5-targeted Allogeneic Gamma-delta CD19 Chimeric Antigen Receptor T Cells for HIV-associated B Cell-malignancy Immunotherapy." Nature Biomedical Engineering 2025. https://doi.org/10.1038/s41551-025-01527-0.

MLA (9th ed.) Citation

Á, Ramírez-Fernández, et al. "CCR5-targeted Allogeneic Gamma-delta CD19 Chimeric Antigen Receptor T Cells for HIV-associated B Cell-malignancy Immunotherapy." Nature Biomedical Engineering, 2025, https://doi.org/10.1038/s41551-025-01527-0.